AstraZeneca $245 Million invest in Cellectis for Therapeutics - Facts Bulletins

factsbulletins.com

AstraZeneca $245 Million invest in Cellectis for Therapeutics - Facts Bulletins

factsbulletins.com

factsbulletins@kbin.run to

kbin.run announcements@kbin.run · 11 months ago

AstraZeneca $245 Million invest in Cellectis for Therapeutics - Facts Bulletins

factsbulletins.com

British pharmaceutical giant AstraZeneca will invest $245 million in French biotech company Cellectis to develop cutting-edge gene therapies

You must log in or register to comment.

Chat

kbin.run announcements@kbin.run

announcements@kbin.run

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !announcements@kbin.run

Community locked: only moderators can create posts. You can still comment on posts.

kbin.run announcements and service advisories will be posted here.

For interactive support and discussion, please join our Matrix room: #kbinrun:matrix.org

Please visit our “cloud-based” monitoring system at https://status.kbin.run/ for real-time technical status and updates.

Rules

@debounced@kbin.run exclusive thread creation

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

1 user / day
4 users / week
2 users / month
9 users / 6 months
1 local subscriber
1 subscriber
14 Posts
13 Comments
Modlog

mods:
debounced@kbin.run

AstraZeneca $245 Million invest in Cellectis for Therapeutics - Facts Bulletins

AstraZeneca $245 Million invest in Cellectis for Therapeutics - Facts Bulletins

AstraZeneca $245 Million&nbsp;invest&nbsp;in Cellectis for Therapeutics - Facts Bulletins

AstraZeneca $245 Million invest in Cellectis for Therapeutics - Facts Bulletins